forty two patients with inoperable non-small cell lung cancer were entered into a phase ii study of the combination chemotherapy regimen pvb ( cisplatin 60 mg/m2 by intravenous infusion over two hours on day 1 , vinblastine 4 mg/m2 by intravenous bolus on days 1 and 2 , and bleomycin 15 mg intramuscularly on days 1 , 8 , and 15 ) , repeated at three weekly intervals .
C0072634
pvb
C0008838
cisplatin